首页> 外文OA文献 >Cell microfactories: manufacturing cell-based therapeutics FIRM abstract

【2h】

Cell microfactories: manufacturing cell-based therapeutics FIRM abstract

机译：细胞微工厂：制造基于细胞的疗法FIRM摘要

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

This is a conference abstract.

机译：这是会议摘要。

著录项

作者
Harrison Richard P.; Thurman-Newell Jamie A.; Petzing Jon N.; Rafiq Qasim A.; Medcalf Nick;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. The controversial origin of pericytes during angiogenesis - Implications for cell-based therapeutic angiogenesis and cell-based therapies [J] . Anna Blocki, Sebastian Beyer, Friedrich Jung, Clinical hemorheology and microcirculation . 2018,第1a2期

机译：血管生成期间的争议起源 - 对细胞基治疗血管生成和基于细胞疗法的影响
2. Special issue on Cell Therapy Manufacturing and Scale-Up Introduction: TA Brieva, Celgene, Co-Chair, Scale-up and Manufacturing of Cell-based Therapies IV [J] . Biochemical Engineering Journal . 2016,第Null期

机译：细胞疗法的制造和放大的特刊简介：TA Brieva，Celgene，共同主席，细胞疗法的放大和制造IV
3. Abstract No. 1 ■ ABSTRACT OF THE YEAR Randomized, double-blind placebo-controlled trial for evaluating safety and therapeutic efficacy of angiogenesis induced by intraarterial autologous bone marrow–derived stem cells in patients with critical limb ischemia [J] . S. Sharma, S. Kumar, K. Nath, Journal of vascular and interventional radiology: JVIR . 2018,第4Suppla期

机译：摘要第1号■摘要随机，双盲安慰剂对照试验，用于评估临床自体骨髓源骨髓源性干细胞患者患者临界自体骨髓源病患者患者临界肢体缺血的安全性和治疗疗效
4. Selection of Monoclonal Antibodies Targeting Therapeutic Membrane Proteins Through a Cell-Based Phage Display Panning System [C] . Yu Jung Kim, Bin Yoo, Yoonji Kim, Protein Engineering Summit. . 2018

机译：通过基于细胞的噬菌体展示平移系统靶向治疗膜蛋白的单克隆抗体的选择
5. MicroRNA-124-Loaded Nanoparticles as a New Promising Therapeutic Tool for Neural Stem Cell-Based Brain Repair Strategies [D] . Saraiva, Cláudia Marisa Monteiro 2017

机译：MicroRNA-124负载纳米粒子作为神经干细胞的脑修复策略的新有前途的治疗工具
6. Gaps between Asian regulations for eligibility of human mesenchymal stromal cells as starting materials of cell therapy products and comparability of mesenchymal stromal cell-based products subject to changes in their manufacturing process [O] . Toshimitsu Tanaka, Shing-Mou Lee, Mayu Mikami, 2020

机译：亚洲人间充质基质细胞作为细胞疗法原料和间充质基质细胞基产品的起始材料之间的差距其制造工艺变化的间充质基质细胞的可比性
7. Cell microfactories: manufacturing cell-based therapeutics TCES abstract [O] . Harrison Richard P., Thurman-Newell Jamie A., Medcalf Nick, 2016

机译：细胞微工厂：制造基于细胞的疗法TCES摘要

Cell microfactories: manufacturing cell-based therapeutics FIRM abstract

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅